Alzheimer's: New drug Donanemab called a 'turning point' by doctors
The medicine, called Donanemab, slowed down cognitive decline in trials by up to 35% - allowing patients to live independently for longer.
Monday 17 July 2023 20:10, UK
The medicine, called Donanemab, slowed down cognitive decline in trials by up to 35% - allowing patients to live independently for longer.
Monday 17 July 2023 20:10, UK
